The table below shows Immunome Inc.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
$6.94M
$9.04M
$14.02M
-
-
-
Cost of revenue
-
-
-
-
-
-
Gross profit
-
-
-
-
-
-
R&D
$177.29M
$129.54M
$23.09M
$23.27M
$14.11M
$7.49M
SG&A
$43.77M
IMNM annual revenue (10-K history)
Immunome Inc. reported annual revenue of $6.94M for fiscal year 2025. That is down 23.2% from $9.04M in fiscal 2024. Figures come from the company's audited annual reports as filed with the SEC.